BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11085888)

  • 1. A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice.
    Chiavegatto S; Sun J; Nelson RJ; Schnaar RL
    Exp Neurol; 2000 Dec; 166(2):227-34. PubMed ID: 11085888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects.
    Sheikh KA; Sun J; Liu Y; Kawai H; Crawford TO; Proia RL; Griffin JW; Schnaar RL
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7532-7. PubMed ID: 10377449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular synaptic transmission in aged ganglioside-deficient mice.
    Zitman FM; Todorov B; Verschuuren JJ; Jacobs BC; Furukawa K; Furukawa K; Willison HJ; Plomp JJ
    Neurobiol Aging; 2011 Jan; 32(1):157-67. PubMed ID: 19233512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced motor and sensory functions and emotional response in GM3-only mice: emergence from early stage of life and exacerbation with aging.
    Tajima O; Egashira N; Ohmi Y; Fukue Y; Mishima K; Iwasaki K; Fujiwara M; Inokuchi J; Sugiura Y; Furukawa K; Furukawa K
    Behav Brain Res; 2009 Mar; 198(1):74-82. PubMed ID: 19013484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of GM2/GD2 synthase gene resulted in overt expression of 9-O-acetyl GD3 irrespective of Tis21.
    Furukawa K; Aixinjueluo W; Kasama T; Ohkawa Y; Yoshihara M; Ohmi Y; Tajima O; Suzumura A; Kittaka D; Furukawa K
    J Neurochem; 2008 May; 105(3):1057-66. PubMed ID: 18194438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides.
    Sun J; Shaper NL; Itonori S; Heffer-Lauc M; Sheikh KA; Schnaar RL
    Glycobiology; 2004 Sep; 14(9):851-7. PubMed ID: 15175257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system.
    Takamiya K; Yamamoto A; Furukawa K; Yamashiro S; Shin M; Okada M; Fukumoto S; Haraguchi M; Takeda N; Fujimura K; Sakae M; Kishikawa M; Shiku H; Furukawa K; Aizawa S
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10662-7. PubMed ID: 8855236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice.
    Ohmi Y; Tajima O; Ohkawa Y; Yamauchi Y; Sugiura Y; Furukawa K; Furukawa K
    J Neurochem; 2011 Mar; 116(5):926-35. PubMed ID: 21214571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular synaptic function in mice lacking major subsets of gangliosides.
    Zitman FM; Todorov B; Jacobs BC; Verschuuren JJ; Furukawa K; Furukawa K; Willison HJ; Plomp JJ
    Neuroscience; 2008 Oct; 156(4):885-97. PubMed ID: 18801416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.
    Pan B; Fromholt SE; Hess EJ; Crawford TO; Griffin JW; Sheikh KA; Schnaar RL
    Exp Neurol; 2005 Sep; 195(1):208-17. PubMed ID: 15953602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of membrane lipids and in gene expression of ganglioside metabolism in different brain structures in a mouse model of mucopolysaccharidosis type I (MPS I).
    Kreutz F; dos Santos Petry F; Camassola M; Schein V; Guma FC; Nardi NB; Trindade VM
    Gene; 2013 Sep; 527(1):109-14. PubMed ID: 23774686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits.
    Glynn D; Drew CJ; Reim K; Brose N; Morton AJ
    Hum Mol Genet; 2005 Aug; 14(16):2369-85. PubMed ID: 16000319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of muscarinic acetylcholine receptors as a substantial basis for progressive neurological deterioration in GM3-only mice.
    Tajima O; Egashira N; Ohmi Y; Fukue Y; Mishima K; Iwasaki K; Fujiwara M; Sugiura Y; Furukawa K; Furukawa K
    Behav Brain Res; 2010 Jan; 206(1):101-8. PubMed ID: 19744524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines.
    Yamashiro S; Ruan S; Furukawa K; Tai T; Lloyd KO; Shiku H; Furukawa K
    Cancer Res; 1993 Nov; 53(22):5395-400. PubMed ID: 8221677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential changes in axonal conduction following CNS demyelination in two mouse models.
    Bando Y; Takakusaki K; Ito S; Terayama R; Kashiwayanagi M; Yoshida S
    Eur J Neurosci; 2008 Nov; 28(9):1731-42. PubMed ID: 18973589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early motor development is abnormal in complexin 1 knockout mice.
    Glynn D; Sizemore RJ; Morton AJ
    Neurobiol Dis; 2007 Mar; 25(3):483-95. PubMed ID: 17188502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.
    Li H; Turley SD; Liu B; Repa JJ; Dietschy JM
    J Lipid Res; 2008 Aug; 49(8):1816-28. PubMed ID: 18450647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
    Lopate G; Choksi R; Pestronk A
    Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice.
    Niimi K; Nishioka C; Miyamoto T; Takahashi E; Miyoshi I; Itakura C; Yamashita T
    Biochem Biophys Res Commun; 2011 Mar; 406(4):524-8. PubMed ID: 21333627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
    Baek RC; Kasperzyk JL; Platt FM; Seyfried TN
    Neurochem Int; 2008 May; 52(6):1125-33. PubMed ID: 18207611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.